Opko
In Brief This Week: Abbott, Thermo Fisher Scientific, Danaher, Oncocyte, Biocartis, More
News items for the week of Feb. 20, 2023.
In Brief This Week: Meridian Bioscience, BARDA, HHS, Oncocyte, GeneDx, More
News items for the week of Jan. 30, 2023.
JP Morgan Healthcare Conference, Day 3: Invitae, Bio-Rad, Bio-Techne, Opko
On the penultimate day of the conference, Invitae provided color on its recent decisions to pull out of certain businesses, while Bio-Rad talked about its clinical plans.
360Dx Top 30 Grows 8 Percent, Continues Upward Climb
Of the 30 companies in the index, 21 saw their stock prices rise, while nine firms' share prices decreased.
Earnings Roundup: OraSure Technologies, LumiraDx, Opko, More
OraSure, LumiraDx, Opko, and Epigenomics reported their financial results this week.
Aug 1, 2022
360Dx Top 30 Rebounds in July After June Swoon
Apr 1, 2022
360Dx Top 30 Falls Slightly in March
Jan 20, 2022
Jan 18, 2022
Sema4 to Acquire GeneDx for $623M
Oct 28, 2021